Your browser doesn't support javascript.
Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context.
Skladany, Lubomir; Koller, Tomas; Adamcova Selcanova, Svetlana; Vnencakova, Janka; Jancekova, Daniela; Durajova, Viktoria; Laffers, Lukas; Svac, Juraj; Janickova, Katarina; Palkovic, Michal; Kohout, Pavel; Golubnitschaja, Olga.
  • Skladany L; HEGITO (Div. Hepatology, Gastroenterology, and Liver Transplantation) of the Department of Internal Medicine II, Faculty of Medicine, Slovak Medical University, F. D. Roosevelt Teaching Hospital, Banska Bystrica, Slovakia.
  • Koller T; 5th Department of Internal Medicine, Comenius University Faculty of Medicine, University Hospital Bratislava Ruzinov, Bratislava, Slovakia.
  • Adamcova Selcanova S; HEGITO (Div. Hepatology, Gastroenterology, and Liver Transplantation) of the Department of Internal Medicine II, Faculty of Medicine, Slovak Medical University, F. D. Roosevelt Teaching Hospital, Banska Bystrica, Slovakia.
  • Vnencakova J; HEGITO (Div. Hepatology, Gastroenterology, and Liver Transplantation) of the Department of Internal Medicine II, Faculty of Medicine, Slovak Medical University, F. D. Roosevelt Teaching Hospital, Banska Bystrica, Slovakia.
  • Jancekova D; HEGITO (Div. Hepatology, Gastroenterology, and Liver Transplantation) of the Department of Internal Medicine II, Faculty of Medicine, Slovak Medical University, F. D. Roosevelt Teaching Hospital, Banska Bystrica, Slovakia.
  • Durajova V; Department of Science and Research, F.D. Roosevelt Teaching Hospital, Banska Bystrica, Slovakia.
  • Laffers L; Department of Mathematics, Faculty of Natural Sciences, Matej Bel University, Banska Bystrica, Slovakia.
  • Svac J; HEGITO (Div. Hepatology, Gastroenterology, and Liver Transplantation) of the Department of Internal Medicine II, Faculty of Medicine, Slovak Medical University, F. D. Roosevelt Teaching Hospital, Banska Bystrica, Slovakia.
  • Janickova K; Central Evidence Department, Health Care Surveillance Authority (HCSA), Bratislava, Slovakia.
  • Palkovic M; Forensic Medicine and Pathological Anatomy Department, Health Care Surveillance Authority (HCSA), Bratislava, Slovakia.
  • Kohout P; Department of Internal Medicine, 3Rd Medical Faculty Charles University, Thomayer Hospital Prague, Prague, Czech Republic.
  • Golubnitschaja O; Predictive, Preventive Personalised (3P) Medicine, Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
EPMA J ; : 1-14, 2021 Mar 03.
Article in English | MEDLINE | ID: covidwho-1227926
Semantic information from SemMedBD (by NLM)
1. Chronic liver disease AFFECTS Patients
Subject
Chronic liver disease
Predicate
AFFECTS
Object
Patients
2. Chronic liver disease PROCESS_OF Patients
Subject
Chronic liver disease
Predicate
PROCESS_OF
Object
Patients
3. Precision Medicine TREATS Chronic disease
Subject
Precision Medicine
Predicate
TREATS
Object
Chronic disease
4. Chronic liver disease AFFECTS Patients
Subject
Chronic liver disease
Predicate
AFFECTS
Object
Patients
5. Chronic liver disease PROCESS_OF Patients
Subject
Chronic liver disease
Predicate
PROCESS_OF
Object
Patients
6. Precision Medicine TREATS Chronic disease
Subject
Precision Medicine
Predicate
TREATS
Object
Chronic disease
ABSTRACT
Chronic liver disease management is a comprehensive approach requiring multi-professional expertise and well-orchestrated healthcare measures thoroughly organized by responsible medical units. Contextually, the corresponding multi-faceted chain of healthcare events is likely to be severely disturbed or even temporarily broken under the force majeure conditions such as global pandemics. Consequently, the chronic liver disease is highly representative for the management of any severe chronic disorder under lasting pandemics with unprecedented numbers of acutely diseased persons who, together with the chronically sick patient cohorts, have to be treated using the given capacity of healthcare systems with their limited resources. Current study aimed at exploring potentially negative impacts of the SARS CoV-2 outbreak on the quality of the advanced chronic liver disease (ACLD) management considering two well-classified parameters, namely, (1) the continuity of the patient registrations and (2) the level of mortality rates, comparing pre-COVID-19 statistics with these under the current pandemic in Slovak Republic. Altogether 1091 registrations to cirrhosis registry (with 60.8% versus 39.2% males to females ratio) were included with a median age of 57 years for patients under consideration. Already within the very first 3 months of the pandemic outbreak in Slovakia (lockdown declared from March 16, 2020, until May 20, 2020), the continuity of the patient registrations has been broken followed by significantly increased ACLD-related death rates. During this period of time, the total number of new registrations decreased by about 60% (15 registrations in 2020 versus 38 in 2018 and 38 in 2019). Corresponding mortality increased by about 52% (23 deaths in 2020 versus 10 in 2018 and 12 in 2019). Based on these results and in line with the framework of 3PM guidelines, the pandemic priority pathways (PPP) are strongly recommended for maintaining tertiary care uninterrupted. For the evidence-based implementation of PPP, creation of predictive algorithms and individualized care strategy tailored to the patient is essential. Resulting classification of measures is summarized as followsThe Green PPP Line is reserved for prioritized (urgent and comprehensive) treatment of patients at highest risk to die from ACLD (tertiary care) as compared to the risk from possible COVID-19 infection.The Orange PPP Line considers patients at middle risk of adverse outcomes from ACLD with re-addressing them to the secondary care. As further deterioration of ACLD is still probable, pro-active management is ascertained with tertiary center serving as the 24/7 telemedicine consultation hub for a secondary facility (on a physician-physician level).The Red PPP Line is related to the patients at low risk to die from ACLD, re-addressing them to the primary care. Since patients with stable chronic liver diseases without advanced fibrosis are at trivial inherent risk, they should be kept out of the healthcare setting as far as possible by the telemedical (patient-nurse or patient- physicianmeasurements. The assigned priority has to be monitored and re-evaluated individually-in intervals based on the baseline prognostic score such as MELD. The approach is conform with principles of predictive, preventive and personalized medicine (PPPM / 3PM) and demonstrates a potential of great clinical utility for an optimal management of any severe chronic disorder (cardiovascular, neurological and cancer) under lasting pandemics.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Clinical Practice Guide / Prognostic study Language: English Journal: EPMA J Year: 2021 Document Type: Article Affiliation country: S13167-021-00231-8

Full text: Available Collection: International databases Database: MEDLINE Type of study: Clinical Practice Guide / Prognostic study Language: English Journal: EPMA J Year: 2021 Document Type: Article Affiliation country: S13167-021-00231-8